Is Paxlovid, the Covid pill, reach­ing those who most need it? The gov­ern­ment won’t say

As the na­tion large­ly aban­dons mask man­dates, phys­i­cal dis­tanc­ing, and oth­er covid-19 pre­ven­tion strate­gies, elect­ed of­fi­cials and health de­part­ments alike are now cham­pi­oning an­tivi­ral pills. But the fed­er­al gov­ern­ment isn’t say­ing how many peo­ple have re­ceived these po­ten­tial­ly life­sav­ing drugs or whether they’re be­ing dis­trib­uted eq­ui­tably.

Pfiz­er’s Paxlovid pill, along with Mer­ck’s mol­nupi­ravir, are aimed at pre­vent­ing vul­ner­a­ble pa­tients with mild or mod­er­ate covid from be­com­ing sick­er or dy­ing. More than 300 Amer­i­cans still die from covid every day.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.